We are live on
!
Find out more
NGM
North Growth Management Portfolio holdings
AUM
$780M
1-Year Est. Return
102.77%
This Fund
S&P 500
This Quarter
Est. Return
-13.33%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
–
AUM
$358M
AUM Growth
-$37.5M
(-9.5%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
40.51%
Holding
48
New
4
Increased
10
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$5.41M |
| 2 |
Coherent
COHR
|
+$5.26M |
| 3 |
First Solar
FSLR
|
+$5M |
| 4 |
Fortune Brands Innovations
FBIN
|
+$4.6M |
| 5 |
Best Buy
BBY
|
+$4.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mohawk Industries
MHK
|
+$9.01M |
| 2 |
Applied Optoelectronics
AAOI
|
+$5.98M |
| 3 |
Pfizer
PFE
|
+$4.46M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.35M |
| 5 |
Cheesecake Factory
CAKE
|
+$2.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 53.02% |
| 2 | Healthcare | 27.1% |
| 3 | Consumer Discretionary | 9.09% |
| 4 | Industrials | 8.74% |
| 5 | Communication Services | 2.04% |
Similar funds
PCM
SAM
QCM
AC
ABWM
HI
LTI
MAM
North Growth Management's Q4 2018 Portfolio in Review
As of Q4 2018, North Growth Management held 48 positions worth $358M, down 9.5% from $395M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
North Growth Management deployed $16.1M of net new capital in Q4 2018, opening 4 new positions and adding to 10 existing holdings. Its largest new stake was Coherent: 141,000 shares worth $4.58M.
By sector, the portfolio is most concentrated in Technology at 53% of assets, up from 52% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $4.46M trimmed.
- North Growth Management's largest Q4 2018 buy was Coherent: 141,000 shares worth $4.58M.
- North Growth Management added most to Electronic Arts in Q4 2018, an estimated $5.41M increase.
- North Growth Management's biggest Q4 2018 reduction was Pfizer, cutting an estimated $4.46M.
- North Growth Management fully exited Mohawk Industries in Q4 2018, selling an estimated $9.01M.
- North Growth Management's ten largest holdings make up 41% of its $358M portfolio in Q4 2018.
- North Growth Management opened 4 new positions and closed 5 in Q4 2018.
- North Growth Management's portfolio value fell 9.5% quarter-over-quarter to $358M.
Based on North Growth Management's 13F filing for Q4 2018, filed 12 Feb 2019.